The potential of patient-derived organoids in precision medicine of biliary tract cancer
Mariana Yáñez-Bartolomé(Hebron University), Tian V. Tian(Breast Cancer Research Foundation), Teresa Macarulla(Vall d'Hebron Hospital Universitari)
Cited by 10
Related Papers
Maintenance Olaparib for Germline <i>BRCA</i> -Mutated Metastatic Pancreatic Cancer
|New England Journal of Medicine|2019|2.2k
Infigratinib (BGJ398) in previously treated patients with advanced or metastatic cholangiocarcinoma with FGFR2 fusions or rearrangements: mature results from a multicentre, open-label, single-arm, phase 2 study
|The Lancet. Gastroenterology & hepatology|2021|423
Colorectal cancer intrinsic subtypes predict chemotherapy benefit, deficient mismatch repair and epithelial‐to‐mesenchymal transition
|International Journal of Cancer|2013|350